Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Misonix' ultrasonic wound debrider:

This article was originally published in Clinica

Executive Summary

Misonix SonicOne ultrasonic wound debrider, which was also recently cleared in the US, is expected to be commercialised in North America in the third calendar quarter of 2005. Unlike with other forms of debridement to remove necrotic tissue or foreign material from a wound to expose healthy tissue, physicians using SonicOne can "easily distinguish tissue types and stop debridement when the viable tissue bed is reached", claims the Farmingdale, New York firm. Regarding the product's launch in Canada and the US, Misonix has begun discussions with potential strategic distribution partners and is also contemplating direct sales efforts in niche markets.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055663

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel